Skip to main content

Table 2 Characteristics of patients with muscular dystrophy II (MD2) at follow-up

From: Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study

 

Presence of Late Gadolinium Enhancement

All (n = 22)

No (n = 17)

Yes (n = 5)

Age (years)

58 ± 9

57 ± 9

61 ± 10

Male sex, n (%)

6 (27.3)

4

2

Heart rate (beats per minute)

69 ± 9

68 ± 9

72 ± 11

Systolic BP (mmHg)

130 ± 16

127 ± 16

139 ± 16

Diastolic BP (mmHg)

75 ± 10

73 ± 10

81 ± 9

Arterial hypertension, n (%)

7 (31.8)

4

3

Hyperlipidemia, n (%)

16 (72.7)

13

3

Diabetes mellitus, n (%)

3 (13.6)

3

–

Smoking, n (%)

2 (9.1)

1

1

Cardiac symptoms

 Asymptomatic, n (%)

16 (72.7)

11

2

 Palpitations, n (%)

6 (27.3)

4

2

 Chest pain, n (%)

1(4.5)

1

0

 Fatigue, n (%)

5 (22.7)

4

1

  1. Data are shown as mean values ± standard deviation (SD) according to the AHA-segment model. BP blood pressure